Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Receivables: 2024

Historic Receivables for Madrigal Pharmaceuticals (MDGL) over the last 1 years, with Dec 2024 value amounting to $53.8 million.

  • Madrigal Pharmaceuticals' Receivables rose 271.88% to $113.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $307.8 million, marking a year-over-year change of. This contributed to the annual value of $53.8 million for FY2024, which is N/A change from last year.
  • Per Madrigal Pharmaceuticals' latest filing, its Receivables stood at $53.8 million for FY2024.
  • In the past 5 years, Madrigal Pharmaceuticals' Receivables ranged from a high of $53.8 million in FY2024 and a low of $53.8 million during FY2024.
  • For the 1-year period, Madrigal Pharmaceuticals' Receivables averaged around $53.8 million, with its median value being $53.8 million (2024).